Interestingly, RAB11B, a RAS superfamily member of small GTP-binding proteins, was the only tumor cell gene with significantly different expression between responders and nonresponders pretreatment (Supplementary Fig. 6d), suggesting an absence of intrinsic tumor cell differences between patient groups at baseline. Here, RAB11B is linked to neoplasm.